Pharmaceutical Executive Digital Edition - October 2011
Thirty Years of Pharm Exec
Y. K Hamied : Changing the Dialogue
Y.K. Hamied, PhD, Chairman, Cipla
Fred Frank: Fortune and the Financier
Fred Frank, Vice Chairman, P.J. Solomon Co.
Marck McLellan: An 'A' for Advancing Expectations
Marck McClellan, MD, Director, Engelberg Center for Health Reform, Brookings Institute
Inside the Mind of the CEO: Steve Collis
Pharm Exec sits down with Steve Collis, CEO of AmerisourceBergen to discuss his agenda for retooling the drug distribution giant.
Daniel Vasella: Heart of Success
Daniel Vasella, MD, Chairman, Novartis
Angus Russell: Bravura Performer
Angus Russell, CEO, Shire
Atsushi Nagahisa: Creating Customer Value
Atsushi Nagahisa, President & CEO, RaQualia
Physicians: Still the Vital Connection in Medicine
Jean-Claude Labrune, Chairman & CEO, Cegedim Group
Henry Waxman: "Representing" Healthcare to the Fullest
Henry Waxman, Congressional Representative from Los Angeles, California
IP: Securing a Global Consensus—Can Industry Do It Again?
Harvey Bale, Jr., MD, former Director-General, IFPMA
30 Years of Pharma: Perspective in Numbers, Part 3
Top 10 Companies by Market Share
Dennis Gillings: Minting the Database
Dennis Gillings, Chairman & CEO, Quintils Transnational Corp.
In Establishing the Evidence Base, He Made Science Count
Robert Seidman, Former Chief Pharmacy Officer, Wellpoint
Jane Henney: Lessons from the FDA Front Line
Jane Henney, MD, Former FDA Commissioner
P. Roy Vagelos: Getting to No. 1—and Staying There
P. Roy Vagelos, MD, Chairman Emeritus, Merck
Emerging Markets:The Myths and Traps
Success in the emerging markets depends significantly on navigating the myths and mental traps.
Patient Advocacy: The Last 30 Years
The rise of advocacy groups has helped patients find their voice, but the power to change health profiles remains an elusive goal.
Pharm Exec: 30 Years, 30 Leaders
Pharm Exec celebrates its 30th birthday with a gathering of 30 of the industry's key influencers of the last three decades.
Francis Collins: Guiding a Revolution in Science
Francis Collins, MD, PhD, Director, National Institutes of Health
Abbey Meyers: The "Mother" of Invention
Abbey Meyers, Founder, National Organization of Rare Disorders
Napoleone Ferrara: Curative Powers of Collaboration
Napoleone Ferrara, MD, PhD, Research Fellow, Genentech
Martin Wygod: Arming up for the Digital Revolution
Martin Wygod, Chairman, WebMD
Candan Carabagli: The East is Up
Candan Karabagli, CEO, Abdi Ibrahim A.S.
Sidney Wolfe: Pharma's Unlikely Best Friend
Sidney Wolfe, MD, Director, Public Citizen's Health Research Group
30 Years of Pharma: Perspective in Numbers, Part 2
30 Years of Pharma: Perspective in Numbers
Janet Woodcock: At the Helm of Industry
Janet Woodcock, MD, Director, FDA Center for Drug Evaluation and Research
Sir Michael Rawlins: Regulation and Reputation
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
30 Years of Pharma: Perspective in Numbers, Part 1
Top 10 Products Worldwide
Josef von Rickenbach: The Enterprising CRO
Josef von Rickenbach, President & CEO, Parexel
